New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease need for health care visits. But what is the latest data on SMART therapy and what are the barriers to its use?
The GameChanger: SMART therapy should be the standard of care for most asthma patients.
Host
Jen Moulton, BSPharm
President, CEimpact
Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
Reference
Meta-analysis
https://pubmed.ncbi.nlm.nih.gov/35230437/
Asthma Action Plan
Do You Have an Asthma Action Plan?
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the latest information concerning SMART therapy in asthma.
2. Discuss how healthcare workers can decrease barriers and increase acces to SMART therapy.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-165-H01-P
Initial release date: 05/06/2024
Expiration date: 05/06/2025
Additional CPE details can be found here.